A Prospective Multicenter Comparative Cohort Study of Neoadjuvant Sintilimab Plus Chemotherapy and Chemoradiotherapy in Resectable Clinical Node-Positive Esophageal Squamous Cell Carcinoma
Year: 2026
Type: article
Source: Annals of Surgical Oncology
Authors: Aizemaiti Rusidanmu, Kun Zhou, Xingxin Zhu, Difan Zheng, Zhengliang Tu, Haiping Jiang, Rong Yang, Kanfeng Liu, Huifang Zhang, Xianghua Ye, Haogang Yu, Huanming Yu, Pengliang Xu, Shengxu Zhi, Jianfeng Jing, Xuhui Wu, Gongzhi Wu, Chongxiong Peng, Xuyang Peng, Bin Huang, Yonghong Zheng, Peng Ye
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Keywords: esophageal squamous cell carcinoma, sintilimab, neoadjuvant chemoimmunotherapy, neoadjuvant chemoradiotherapy, resectable esophageal cancer, pathological complete response, nodal downstaging, esophagectomy, platinum-based chemotherapy, systemic immune-inflammation index, inflammatory markers, overall survival
Open Access status: closed
OpenAlex ID: W7166325807
